Literature DB >> 21329961

Transcription factors engaged in development of NK cells are commonly expressed in nasal NK/T-cell lymphomas.

Shuang Zhang1, Ting Li, Bo Zhang, Lin Nong, Katsuyuki Aozasa.   

Abstract

Extranodal natural killer/T (NK/T)-cell lymphoma, nasal type, is a prevailing tumor in Asia with distinct clinical, pathologic, and immunophenotypic features. Previous study revealed amplification and overexpression of T-bet in extranodal NK/T-cell lymphoma, nasal type. As a transcription factor, T-bet functionally cooperates with its family member eomesodermin (EOMES) or ETS family members (ETS-1 and MEF) and positively regulates the development and cytotoxic function of natural killer (NK) cells. To evaluate their role in extranodal NK/T-cell lymphoma, nasal type, the expression status and clinical relevance of these genes were analyzed in 40 cases of this tumor by in situ hybridization and immunohistochemistry. Tumor cells in all 40 cases expressed cytotoxic granule proteins, of which 39 contained the Epstein-Barr virus (EBV) genome. Two (8.7%) of 23 cases showed T-cell receptor (TCR) γ gene clonal rearrangement, confirming cytotoxic T lineage of cell derivation. The expression level of T-bet as revealed by in situ hybridization and immunohistochemistry was high in extranodal NK/T-cell lymphoma, nasal type, (82.5% and 100%) and peripheral T-cell lymphomas (94.4% and 72.2%) but not in mature B-cell lymphomas in our control group (0% and 0%). By in situ hybridization, high expression of EOMES (80.0%), ETS-1 (82.5%), and MEF (62.5%) was observed in cases of extranodal NK/T-cell lymphoma, nasal type, but none of the control groups and cases expressed these molecules. Coexpression of T-bet and EOMES, ETS-1, or MEF was found in 30 (75%), 25 (62.5%), and 21 cases (52.5%), respectively. The frequency of coexpression of T-bet and EOMES was significantly higher than that of other genes. Transcription factors engaged in NK-cell development are highly expressed in extranodal NK/T-cell lymphoma, nasal type, suggesting a role in the biologic behavior of this tumor.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21329961     DOI: 10.1016/j.humpath.2009.11.022

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  6 in total

1.  Molecular mechanisms influencing NK cell development: implications for NK cell malignancies.

Authors:  Sally A Mujaj; Michelle M Spanevello; Maher K Gandhi; Jamie P Nourse
Journal:  Am J Blood Res       Date:  2011-05-22

2.  Inherited variants at 3q13.33 and 3p24.1 are associated with risk of diffuse large B-cell lymphoma and implicate immune pathways.

Authors:  Geffen Kleinstern; Huihuang Yan; Michelle A T Hildebrandt; Joseph Vijai; Sonja I Berndt; Hervé Ghesquières; James McKay; Sophia S Wang; Alexandra Nieters; Yuanqing Ye; Alain Monnereau; Angela R Brooks-Wilson; Qing Lan; Mads Melbye; Rebecca D Jackson; Lauren R Teras; Mark P Purdue; Claire M Vajdic; Roel C H Vermeulen; Graham G Giles; Pier Luigi Cocco; Brenda M Birmann; Peter Kraft; Demetrius Albanes; Anne Zeleniuch-Jacquotte; Simon Crouch; Yawei Zhang; Vivekananda Sarangi; Yan Asmann; Kenneth Offit; Gilles Salles; Xifeng Wu; Karin E Smedby; Christine F Skibola; Susan L Slager; Nathaniel Rothman; Stephen J Chanock; James R Cerhan
Journal:  Hum Mol Genet       Date:  2020-01-01       Impact factor: 6.150

3.  The Genetic Deletion of 6q21 and PRDM1 and Clinical Implications in Extranodal NK/T Cell Lymphoma, Nasal Type.

Authors:  Li Liang; Zhang Zhang; Ying Wang; Lin Nong; Yalin Zheng; Linlin Qu; Bo Zhang; Ting Li
Journal:  Biomed Res Int       Date:  2015-06-29       Impact factor: 3.411

4.  The downregulation of PRDM1/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK/T-cell lymphoma, nasal type.

Authors:  Li Liang; Lin Nong; Shuang Zhang; Jing Zhao; Hongjuan Ti; Ying Dong; Bo Zhang; Ting Li
Journal:  J Exp Clin Cancer Res       Date:  2014-01-17

5.  Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.

Authors:  Matthew Frampton; Miguel Inacio da Silva Filho; Peter Broderick; Hauke Thomsen; Asta Försti; Jayaram Vijayakrishnan; Rosie Cooke; Victor Enciso-Mora; Per Hoffmann; Markus M Nöthen; Amy Lloyd; Amy Holroyd; Lewin Eisele; Karl-Heinz Jöckel; Sabine Ponader; Elke Pogge von Strandmann; Tracy Lightfoot; Eve Roman; Annette Lake; Dorothy Montgomery; Ruth F Jarrett; Anthony J Swerdlow; Andreas Engert; Kari Hemminki; Richard S Houlston
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

6.  Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.

Authors:  Sonja I Berndt; Nicola J Camp; Christine F Skibola; Joseph Vijai; Zhaoming Wang; Jian Gu; Alexandra Nieters; Rachel S Kelly; Karin E Smedby; Alain Monnereau; Wendy Cozen; Angela Cox; Sophia S Wang; Qing Lan; Lauren R Teras; Moara Machado; Meredith Yeager; Angela R Brooks-Wilson; Patricia Hartge; Mark P Purdue; Brenda M Birmann; Claire M Vajdic; Pierluigi Cocco; Yawei Zhang; Graham G Giles; Anne Zeleniuch-Jacquotte; Charles Lawrence; Rebecca Montalvan; Laurie Burdett; Amy Hutchinson; Yuanqing Ye; Timothy G Call; Tait D Shanafelt; Anne J Novak; Neil E Kay; Mark Liebow; Julie M Cunningham; Cristine Allmer; Henrik Hjalgrim; Hans-Olov Adami; Mads Melbye; Bengt Glimelius; Ellen T Chang; Martha Glenn; Karen Curtin; Lisa A Cannon-Albright; W Ryan Diver; Brian K Link; George J Weiner; Lucia Conde; Paige M Bracci; Jacques Riby; Donna K Arnett; Degui Zhi; Justin M Leach; Elizabeth A Holly; Rebecca D Jackson; Lesley F Tinker; Yolanda Benavente; Núria Sala; Delphine Casabonne; Nikolaus Becker; Paolo Boffetta; Paul Brennan; Lenka Foretova; Marc Maynadie; James McKay; Anthony Staines; Kari G Chaffee; Sara J Achenbach; Celine M Vachon; Lynn R Goldin; Sara S Strom; Jose F Leis; J Brice Weinberg; Neil E Caporaso; Aaron D Norman; Anneclaire J De Roos; Lindsay M Morton; Richard K Severson; Elio Riboli; Paolo Vineis; Rudolph Kaaks; Giovanna Masala; Elisabete Weiderpass; María-Dolores Chirlaque; Roel C H Vermeulen; Ruth C Travis; Melissa C Southey; Roger L Milne; Demetrius Albanes; Jarmo Virtamo; Stephanie Weinstein; Jacqueline Clavel; Tongzhang Zheng; Theodore R Holford; Danylo J Villano; Ann Maria; John J Spinelli; Randy D Gascoyne; Joseph M Connors; Kimberly A Bertrand; Edward Giovannucci; Peter Kraft; Anne Kricker; Jenny Turner; Maria Grazia Ennas; Giovanni M Ferri; Lucia Miligi; Liming Liang; Baoshan Ma; Jinyan Huang; Simon Crouch; Ju-Hyun Park; Nilanjan Chatterjee; Kari E North; John A Snowden; Josh Wright; Joseph F Fraumeni; Kenneth Offit; Xifeng Wu; Silvia de Sanjose; James R Cerhan; Stephen J Chanock; Nathaniel Rothman; Susan L Slager
Journal:  Nat Commun       Date:  2016-03-09       Impact factor: 17.694

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.